I-Mab Biopharma Announces Clinical Collaboration to Evaluate TJC4 in Combination with KEYTRUDA (pembrolizumab) Read more
Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals Read more
Chairs post an invitation letter for the 12th Annual Pre-Filled Syringes and Injectable Drugs conference Read more